HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oligosymptomatic neurosyphilis with false negative CSF-VDRL in HIV-infected individuals?

Abstract
The true prevalence of neurosyphilis in HIV-infection is unknown, since a sufficiently sensitive and specific test is lacking. In a prospective study we found reactive serum TPHA and FTA-ABS IgG tests in 95 (31%) of 307 HIV-infected patients. Three of 11 patients with latent syphilis revealed reactive CSF-VDRL tests, six others only demonstrated CSF abnormalities. Resolution of CSF abnormalities during a six month follow up after high dose antibiotic therapy led to the diagnosis of oligosymptomatic or asymptomatic neurosyphilis in all nine patients. Thus, the specificity of the CSF-VDRL was 100%, but the sensitivity was only 33%. The overall prevalence of neurosyphilis was 2.9%, increasing to 9.5% in patients with a reactive serum TPHA. Our study emphasizes the importance of antibiotic therapy for presumptive neurosyphilis in HIV-infected patients with latent syphilis and CSF abnormalities but nonreactive CSF-VDRL tests, even if they are neurologically asymptomatic or present with complaints inconclusive of neurosyphilis.
AuthorsR Malessa, M W Agelink, U Hengge, L Mertins, M Gastpar, N H Brockmeyer
JournalEuropean journal of medical research (Eur J Med Res) Vol. 1 Issue 6 Pg. 299-302 (Mar 19 1996) ISSN: 0949-2321 [Print] England
PMID9367943 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Cardiolipins
  • Penicillins
  • Phosphatidylcholines
  • VDRL antigen
  • Erythromycin
  • Cholesterol
  • Penicillin G
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Cardiolipins (cerebrospinal fluid)
  • Cholesterol (cerebrospinal fluid)
  • Erythromycin (therapeutic use)
  • False Negative Reactions
  • HIV Infections (complications)
  • HIV Seropositivity (complications)
  • Humans
  • Male
  • Middle Aged
  • Neurosyphilis (complications, diagnosis, drug therapy, epidemiology)
  • Penicillin G (therapeutic use)
  • Penicillins (therapeutic use)
  • Phosphatidylcholines (cerebrospinal fluid)
  • Prevalence
  • Reproducibility of Results
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: